The therapeutic role of ivabradine in heart failure

被引：26
|
作者：
Badu-Boateng, Charles [2 ]
Jennings, Robert [2 ]
Hammersley, Daniel [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Dept Cardiol, Denmark Hill, London SE5 9RS, England
[2] Frimley Pk Hosp, Dept Med, Frimley, Camberley, England
来源：
THERAPEUTIC ADVANCES IN CHRONIC DISEASE | 2018年 / 9卷 / 11期
关键词：
drug therapy; heart failure; ivabradine; CORONARY-ARTERY-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; QUALITY-OF-LIFE; I-F INHIBITOR; RATE REDUCTION; CARDIAC-RHYTHM; OUTCOMES; MORTALITY; METAANALYSIS; BEAUTIFUL;
D O I：
10.1177/2040622318784556
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Heart failure represents a major global cause of morbidity and mortality. Ivabradine is a selective funny current (I-f) inhibitor, which acts on the sinoatrial node, resulting in a reduction in heart rate. Ivabradine is currently licensed for use in patients with symptomatic heart failure with reduced ejection fraction and a heart rate persistently at least 70 beats per minute in spite of otherwise optimal prognostic heart failure pharmacotherapy. In this review article, we examine the mechanism of action of ivabradine, evaluate the clinical trials underpinning its application in heart failure and discuss its current recommended clinical use in this capacity.
引用
收藏
页码：199 / 207
页数：9
相关论文
共 50 条
  • [1] Heart rate and heart failure: the role of ivabradine therapy
    Reil, Jan-Christian
    Boehm, Michael
    [J]. CURRENT OPINION IN CARDIOLOGY, 2013, 28 (03) : 326 - 331
  • [2] The role of heart rate and ivabradine in acute heart failure
    Sciatti, Edoardo
    Vizzardi, Enrico
    Dallapellegrina, Lucia
    Bonadei, Ivano
    Carubelli, Valentina
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2019, 89 (03) : 11 - 16
  • [3] Advances in the management of heart failure: the role of ivabradine
    Mueller-Werdan, Ursula
    Stoeckl, Georg
    Werdan, Karl
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 453 - 470
  • [4] Ivabradine: Role in the Chronic Heart Failure Armamentarium
    Psotka, Mitchell A.
    Teerlink, John R.
    [J]. CIRCULATION, 2016, 133 (21) : 2066 - 2075
  • [5] Limited role for ivabradine in the treatment of chronic heart failure
    Cullington, Damien
    Goode, Kevin M.
    Cleland, John G. F.
    Clark, Andrew L.
    [J]. HEART, 2011, 97 (23) : 1961 - 1966
  • [6] Ivabradine in Acute Heart Failure: A Therapeutic Means for Effective Heart Rate Control
    Treptau, Jens
    Jeske, Ole
    Napp, Christian
    Menon, Akshay
    Schieffer, Bernhard
    Schaefer, Andreas
    Bauersachs, Johann
    Tongers, Joern
    [J]. CIRCULATION, 2015, 132
  • [7] Nemaline myopathy and heart failure: role of ivabradine; a case report
    Sarullo, Filippo M.
    Vitale, Giuseppe
    Di Franco, Antonino
    Sarullo, Silvia
    Salerno, Ylenia
    Vassallo, Laura
    Baviera, Emanuela Petrona
    Marazia, Stefania
    Mandala, Giorgio
    Lanza, Gaetano A.
    [J]. BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [8] Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
    Nadeem, Muhammad
    Hassib, Mohab
    Aslam, Hafiz M.
    Fatima, Dania
    Illahi, Yasir
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [9] The role of ivabradine in the treatment of heart failure - State of the art for 2014
    Kasprzak, Jaroslaw D.
    [J]. KARDIOLOGIA POLSKA, 2014, 72
  • [10] Nemaline myopathy and heart failure: role of ivabradine; a case report
    Filippo M Sarullo
    Giuseppe Vitale
    Antonino Di Franco
    Silvia Sarullo
    Ylenia Salerno
    Laura Vassallo
    Emanuela Petrona Baviera
    Stefania Marazia
    Giorgio Mandalà
    Gaetano A Lanza
    [J]. BMC Cardiovascular Disorders, 15
12345